% Expired Patents = 16.7

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 9

Loading Chart...

9 inventors (with patents filed for the assignee):

Klas Wiman (5 out of 5 patents)

Vladimir Bykov (4 out of 4 patents)

Galina Selivanova (4 out of 4 patents)

4. Styrbjörn Byström (1 out of 12 patents)

5. Charlotta Liljebris (1 out of 2 patents)

6. Ninus Caram-Lelham (1 out of 1 patent)

7. Marianne Farnebo (1 out of 1 patent)

8. Salah Mahmoudi (1 out of 1 patent)

9. Jacob Westman (1 out of 4 patents)

10. Jacob Westman (0 patent)

6 patents: Sort by Forward Citations

1. 9061016 - Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease (2015-06-23),

2. 7902167 - Compounds and methods for down-regulating Wrap53 protein by RNA interference (2011-03-08),

3. 7759361 - Azabicyclooctan-3-one derivatives and use thereof (2010-07-20),

4. 7659278 - Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases (2010-02-09),

5. 7348330 - 1-azabicyclo [2,2,2] octan-3-one derivatives (2008-03-25),

6. 6921765 - 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors (2005-07-26),

Company Overview

Aprea Ab is a biopharmaceutical company focused on developing novel cancer therapies. The company's lead drug candidate, APR-246, is being evaluated in multiple clinical trials for the treatment of various types of cancers. Aprea Ab is dedicated to advancing the field of oncology and improving outcomes for cancer patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#30 in Solna

#927 in Sweden

Solna, Sweden

Aprea Ab

Forward Citations = 9

9 inventors:

Klas Wiman (5 out of 5 patents)

Vladimir Bykov (4 out of 4 patents)

Galina Selivanova (4 out of 4 patents)

4. Styrbjörn Byström (1 out of 12 patents)

5. Charlotta Liljebris (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aprea Ab. Retrieved from https://idiyas.com/company/aprea-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]